Loading...
A90 A UTILITY-BASED BAYESIAN OPTIMAL INTERVAL (U-BOIN) PHASE I/II DESIGN TO IDENTIFY THE OPTIMAL BIOLOGICAL DOSE FOR TARGETED AND IMMUNE THERAPIES
BACKGROUND: In the era of targeted therapy and immunotherapy, the objective of dose finding is often to identify the optimal biological dose (OBD), rather than the maximum tolerated dose (MTD). AIMS: To develop a utility-based Bayesian optimal interval (U-BOIN) phase I/II design to find the OBD. MET...
Na minha lista:
| Udgivet i: | J Can Assoc Gastroenterol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7043509/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.089 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|